Quantitative comparison of drusen segmented on SD-OCT versus drusen delineated on color fundus photographs.
OBJECTIVE
Spectral domain-optical coherence tomography (SD-OCT) may be useful for efficient measurement of drusen in patients with age-related macular degeneration (AMD). Areas identified as drusen from semiautomated segmentation of drusen on SD-OCT were compared to those identified from review of digital color fundus photographs (CFPs).


METHODS
Twelve eyes with nonneovascular AMD were prospectively imaged with digital CFP and SD-OCT. For each eye, areas on CFP in which at least two of three retina specialists agreed on drusen presence produced the composite CFP drusen map. Automated image analysis produced another CFP map. Areas identified as drusen by segmentation on SD-OCT B-scans were plotted as the SD-OCT drusen map. The CFP and SD-OCT maps were compared and agreement was quantified. Disagreement was characterized into distinct types, and the frequency of each type was quantified.


RESULTS
There was general agreement between CFP and SD-OCT in identifying presence and absence of drusen, with mean agreement in 82% ± 9% of total image pixels. Most disagreement (80% ± 15%) occurred at drusen margins. There was a trend toward greater detection of drusen with SD-OCT in eyes with larger drusen and with hyperpigmentation. There was a trend toward greater detection of smaller drusen by CFP.


CONCLUSIONS
Good agreement was demonstrated in drusen detection between CFP and SD-OCT. Areas of disagreement underscore limitations of CFP-based measurement of drusen, particularly in the sizing of large, soft drusen. SD-OCT shows great promise as an adjunctive tool for assessing drusen burden in AMD. (ClinicalTrials.gov number, NCT00734487.).
Jain
Nieraj
N
Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, USA.
Farsiu
Sina
S
Khanifar
Aziz A
AA
Bearelly
Srilaxmi
S
Smith
R Theodore
RT
Izatt
Joseph A
JA
Toth
Cynthia A
CA
D000465:Algorithms; D003941:Diagnostic Techniques, Ophthalmological; D005654:Fundus Oculi; D006801:Humans; D008268:Macular Degeneration / Q000175:diagnosis*; D015588:Observer Variation; D010781:Photography / Q000295:instrumentation*; D011446:Prospective Studies; D015203:Reproducibility of Results; D015593:Retinal Drusen / Q000175:diagnosis*; D041623:Tomography, Optical Coherence / Q000295:instrumentation*
Ophthalmology. 2002 Oct;109(10):1767-79
12359593
Ophthalmology. 2009 Mar;116(3):488-496.e2
19167082
Ophthalmology. 2005 Oct;112(10):1734-46
16140383
Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5495-504
17122141
Br J Ophthalmol. 2005 Jan;89(1):87-91
15615753
Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2655-61
16723483
IEEE Trans Image Process. 1998;7(3):359-69
18276256
Br J Ophthalmol. 2009 Feb;93(2):176-81
18697811
Ophthalmology. 2008 Nov;115(11):1883-90
18722666
Surv Ophthalmol. 1995 Mar-Apr;39(5):367-74
7604360
IEEE Trans Image Process. 2007 Feb;16(2):349-66
17269630
Ophthalmology. 2008 Jun;115(6):1026-31
17981333
Arch Ophthalmol. 1990 Oct;108(10):1442-7
1699513
Ophthalmology. 1991 Jul;98(7):1128-34
1843453
Arch Ophthalmol. 2005 Feb;123(2):200-6
15710816
Arch Ophthalmol. 2005 Nov;123(11):1484-98
16286610
Ophthalmology. 2006 Nov;113(11):2054.e1-14
17074565
Stat Methods Med Res. 1999 Jun;8(2):135-60
10501650
Conf Rec Asilomar Conf Signals Syst Comput. 2008 Oct 26;42:651-654
21297895
Arch Ophthalmol. 2003 May;121(5):695-706
12742848
Ophthalmology. 1999 Jun;106(6):1119-25
10366080
Arch Ophthalmol. 2003 May;121(5):658-63
12742843
Arch Ophthalmol. 2003 Apr;121(4):519-26
12695249
Am J Ophthalmol. 2001 Nov;132(5):668-81
11704028
Retina. 2022 May 1;42(5):842-851
35174809
Retina. 2008 Feb;28(2):298-308
18301035
Br J Ophthalmol. 2006 Feb;90(2):191-7
16424532
Opt Express. 2005 Jan 24;13(2):444-52
19488371